XTAE
RIMO
Market cap109mUSD
May 22, Last price
4,685.00ILS
1D
-0.34%
1Q
-9.61%
Jan 2017
-3.70%
Name
Rimoni Industries Ltd
Chart & Performance
Profile
Rimoni Industries Ltd. engages in the design, engineering, and manufacturing of molds, and precise injection molding and assemblies for the medical, automotive, agricultural, high-tech, and consumer industries in Israel. The company offers hardened steel molds, including multi-cavity molds, molds with hot runner systems, prototype molds for complex and intricate products, molds for micro-precision parts, over-moldings, and others. It also provides plastic parts by thermoplastic injection molding; and assembly services for injection molding products. The company was founded in 1954 and is based in Modi'in-Maccabim-Re'ut, Israel.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 182,974 -14.14% | 213,114 -0.08% | 213,295 3.66% | |||||||
Cost of revenue | 131,612 | 164,524 | 151,417 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 51,362 | 48,590 | 61,878 | |||||||
NOPBT Margin | 28.07% | 22.80% | 29.01% | |||||||
Operating Taxes | 4,729 | 5,349 | 5,742 | |||||||
Tax Rate | 9.21% | 11.01% | 9.28% | |||||||
NOPAT | 46,633 | 43,241 | 56,136 | |||||||
Net income | 41,271 -1.53% | 41,911 -12.38% | 47,833 1.55% | |||||||
Dividends | (40,842) | (20,505) | (55,633) | |||||||
Dividend yield | 10.19% | 4.52% | 9.89% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 1,051 | 717 | 22,543 | |||||||
Long-term debt | 4,063 | 2,851 | 4,095 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 1,351 | 5,079 | 1,459 | |||||||
Net debt | (16,495) | (9,769) | 23,009 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 49,735 | 58,878 | 48,924 | |||||||
CAPEX | (3,185) | (3,827) | (12,641) | |||||||
Cash from investing activities | (3,183) | (5,346) | (12,343) | |||||||
Cash from financing activities | (37,417) | (43,163) | (61,607) | |||||||
FCF | 53,038 | 52,016 | 22,743 | |||||||
Balance | ||||||||||
Cash | 21,609 | 13,337 | 3,629 | |||||||
Long term investments | ||||||||||
Excess cash | 12,460 | 2,681 | ||||||||
Stockholders' equity | 149,123 | 149,094 | 127,288 | |||||||
Invested Capital | 172,666 | 184,858 | 181,847 | |||||||
ROIC | 26.09% | 23.58% | 34.19% | |||||||
ROCE | 27.29% | 25.91% | 33.37% | |||||||
EV | ||||||||||
Common stock shares outstanding | 8,404 | 8,404 | 8,404 | |||||||
Price | 47.68 -11.65% | 53.97 -19.36% | 66.93 -18.37% | |||||||
Market cap | 400,703 -11.65% | 453,564 -19.36% | 562,480 -18.37% | |||||||
EV | 384,208 | 444,195 | 587,582 | |||||||
EBITDA | 59,561 | 57,047 | 70,481 | |||||||
EV/EBITDA | 6.45 | 7.79 | 8.34 | |||||||
Interest | 121 | 441 | 798 | |||||||
Interest/NOPBT | 0.24% | 0.91% | 1.29% |